Inhibit liver fibrosis in non-alcoholic fatty liver disease mice model (17);  In contrast, PAR2 knockout increases cardiac fibrosis due to compensatory augmented PAR1 (18). This evidence concerns the gene F2RL1 and metabolic dysfunction-associated steatotic liver disease.